KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Income towards Parent Company: 2012-2025

Historic Income towards Parent Company for Sarepta Therapeutics (SRPT) over the last 12 years, with Jun 2025 value amounting to -$447.6 million.

  • Sarepta Therapeutics' Income towards Parent Company fell 7028.08% to -$447.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$248.7 million, marking a year-over-year decrease of 627.64%. This contributed to the annual value of $235.0 million for FY2024, which is 143.83% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Income towards Parent Company stood at -$447.6 million for Q2 2025, which was down 381.84% from $158.8 million recorded in Q4 2024.
  • Sarepta Therapeutics' 5-year Income towards Parent Company high stood at $158.8 million for Q4 2024, and its period low was -$516.8 million during Q1 2023.
  • Its 3-year average for Income towards Parent Company is -$83.2 million, with a median of $6.5 million in 2024.
  • Per our database at Business Quant, Sarepta Therapeutics' Income towards Parent Company surged by 248.80% in 2024 and then tumbled by 7,028.08% in 2025.
  • Sarepta Therapeutics' Income towards Parent Company (Quarterly) stood at -$122.0 million in 2021, then increased by 9.94% to -$109.9 million in 2022, then soared by 141.44% to $45.5 million in 2023, then skyrocketed by 248.80% to $158.8 million in 2024, then crashed by 7,028.08% to -$447.6 million in 2025.
  • Its Income towards Parent Company was -$447.6 million in Q2 2025, compared to $158.8 million in Q4 2024 and $33.6 million in Q3 2024.